Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers

Clinical Cancer Research

Volumn 11, Issue 18, 2005, Pages 6479-6488

  Sakakura, Chouhei ^a,b   Hasegawa, Kazunori ^c   Miyagawa, Koji ^a   Nakashima, Susumu ^a   Yoshikawa, Tetsuji ^a   Kin, Shuichi ^a   Nakase, Yuenn ^a   Yazumi, Shujiro ^c   Yamagishi, Hisakazu ^a   Okanoue, Takeshi ^b   Chiba, Tsutomu ^c   Hagiwara, Akeo ^a  

^a Division of Digestive Surgery   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN E; DECAY ACCELERATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 10; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWNSTREAM PROCESSING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, NORTHERN; CELL LINE, TUMOR; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONEAL NEOPLASMS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 25144449065     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0729     Document Type: Article

References (44)

1. Yamazaki H, Oshima A, Murakami R, Endoh S, Ubukata T. A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer 1989;63:613-7.
2. Kodera Y, Yamamura Y, Torii A, et al. Postoperative staging of gastric carcinoma. A comparison between the UICC stage classification and the 12th edition of the Japanese General Rules for Gastric Cancer Study. Stand J Gastroenterol 1996;31:476-80.
3. Baba H, Korenaga D, Okamura T, Saito A, Sugimach K. Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. Arch Surg 1989;124:1061-4.
4. El-Rifai W, Frierson HF, Jr., Harper JC, Powell SM, Knuutila S. Expression profiling of gastric adenocarcinoma using cDNA array. Int J Cancer 2001;92:832-8.
5. Hippo Y, Yashiro M, Ishii M, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001;61:889-95.
6. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24.
7. Sakakura C, Yamaguchi-Iwai Y, Satake M, et al. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AMLI/MTGS(ETO)-specific antisense oligonucleotide. Proc Natl Acad Sci USA 1994;91:11723-7.
8. Sakakura C, Sweeney EA, Shirahama T, et al. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 1996;67:101-5.
9. Sakakura C, Sweeney EA, Shirahama T, Hakomori S, Igarashi Y. Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Lett 1996;379:177-80.
10. Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002;111:621-33.
11. Sakakura C, Takemura M, Hagiwara A, et al. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br J Cancer 2004;90:665-71.
12. Herman JG, Graft JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1993;93:9821-6.
13. Nakase Y, Sakakura C, Miyagawa K, et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Br J Cancer 2005;92:562-9.
14. Miki R, Kadota K, Bono H, et al. Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A 2000;98:2199-204.
15. Sakakura C, Hagiwara A, Nakanishi M, et al. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer 2002;87:1153-61.
16. Kaota K, Miki R, Bono H, Shimizu K, Okazaki Y, Hayashizaki Y. Preprocessing implementation for microarray (PRIM): an efficient method for processing cDNA microarray data. Physiol Genomics 2001;4:183-8.
17. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
18. Hanai J, Chen LF, Kanno T, et al. Interaction and functional cooperation of PEBP2CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 1999;274:31577-82.
19. Otto F, Lubber M, Stock M. Upstream and down-stream targets of RUNX proteins. J Cell Biochem 2003;89:9-18.
20. Puig-Kroger A, Sanchez-Elsner T, Ruiz N, et al. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 2003;102:3252-61.
21. Paredes R, Arriagada G, Cruzat F, et al. Bone-specific transcription factor Runx2 interacts with the 1α,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 2004;24:8847-61.
22. Javed A, Quo B, Hiebert S, et al. Groucho/TLE/ R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(α)/AML/PEBP2(α)) dependent activation of tissue-specific gene transcription. J Cell Sci 2000;113:2221-31.
23. Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002;111:621-33.
24. Levanon D, Bettoun D, Harris-Cerruti C, et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J 2002;21:3454-63.
25. Taniguchi K, Yonemura Y, Nojima N, et al. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer 1998;82:2112-22.
26. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003;3:347-61.
27. Hippo Y, Yashiro M, Ishii M, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001;61:889-95.
28. Julien S, Lagadec C, Krzewinski-Recchi MA, Courtand G, Bourhis XL, Delannoy P. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. Breast Cancer Res Treat 2005;90:77-84.
29. Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D, Tahara E. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int J Cancer 1994;56:474-80.
30. Zvibel I, Brill S, Halpern Z, Papa M. Amphiregulin and hepatocyte-derived extracellular matrix regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver-colonizing capacity. J Cell Biol 1999;76:332-40.
31. Kurihara LJ, Semenova E, Miller W, Ingram RS, Guan XJ, Tilghman SM. Candidate genes required for embryonic development: a comparative analysis of distal mouse chromosome 14 and human chromosome 13q22. Genomics 2002;79:154-61.
32. Putilina T, Jaworski C, Gentleman S, McDonald B, Kadiri M, Wong P. Analysis of a human c DNA containing a tissue-specific alternatively spliced LIM domain. Biochem Biophys Res Commun 1998;252:433-9.
33. Sutherland KD, Visvader JE, Choong DY, Sum EY Lindeman GJ, Campbell IG. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas. Int J Cancer 2003;107:155-8.
34. Hilger RA, Scheulen ME, Strumberg D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 2002;25:511-8.
35. Matsuo K, Kobayashi I, Tsukuba T et al. Immunohistochemical localization of cathepsins D and E in human gastric cancer: a possible correlation with local invasive and metastatic activities of carcinoma cells. Hum Pathol 1996;27:184-90.
36. Zeng L, Sachdev P, Yan L, et al. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol 2000;20:9212-24.
37. Laxmikanthan G, Blaber SI, Bernett MJ, Scarisbrick IA, Juliano MA, Blaber M. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins 2005;58:802-14.
38. Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH. Involvement of interferon regulatory factor 1 and S100C/AII in growth inhibition by transforming growth factor β1 in human hepatocellular carcinoma cells. Cancer Res 2004;64:4155-61.
39. Teratani T, Watanabe T, Kuwahara F, et al. Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes human renal carcinoma. Cancer Lett 2002;175:71-7.
40. Mizokami Y, Kajiyama H, Shibata K, Ino K, Kikkawa F, Mizutani S. Stromal cell-derived factor-1α-induced cell proliferation and its possible regulation by CD26/ dipeptidyl peptidase IV in endometrial adenocarcinoma. Int J Cancer 2004;110:652-9.
41. Clevers H. At the crossroads of inflammation and cancer. Cell 2004;118:671-4.
42. Holla VR, Wang D, Brown JR, Mann JR, Katkuri S, DuBois RN. Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer. J Biol Chem 2005;280:476-83.
43. Park IC, Park MJ, Hwang CS, et al. Mitomycin C induces apoptosis in a caspases-dependent and Fas/ CD95-independent manner in human gastric adenocarcinoma cells. Cancer Lett 2000;158:125-32.
44. 6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer. Jpn J Clin Oncol 2005;35:121-5.